2027 Medicare MIPS Changes: New Core Measures and the Transition to MVPs

The Centers for Medicare & Medicaid Services (CMS) has finalized significant changes to the Merit-based Incentive Payment System (MIPS) under the Calendar Year 2027 Medicare Physician Fee Schedule Final Rule.

These updates affect how eligible clinicians select quality measures, report performance data, and prepare for the transition toward MIPS Value Pathways (MVPs).

One of the most important changes begins with the 2027 performance period: eligible clinicians must report at least one applicable MIPS Core Measure as part of their quality reporting requirements, subject to the finalized exceptions.

CMS has also finalized three new MVPs focused on:

• Diabetes: A reporting pathway for clinicians treating patients with diabetic disease.

• Hypertension: A pathway focused on hypertension care and related quality outcomes.

• Hospitalists: A reporting option designed for clinicians providing hospital-based care.

Another major development is the planned end of traditional MIPS. CMS will maintain the traditional reporting option through the 2030 performance period. Beginning with the 2031 performance period, eligible clinicians will transition to MVP reporting unless they qualify to report through the Alternative Payment Model (APM) Performance Pathway.

These changes make 2027 an important preparation year for medical practices. Clinicians and administrators should review their current reporting methods, specialty measure selections, EHR data collection, and quality management processes before the new performance period begins.

What Is the New MIPS Core Measure Requirement for 2027?

CMS is introducing a new Core Measure requirement to make quality reporting more consistent and relevant to the clinical specialties participating in MIPS.

Beginning with the 2027 performance period, eligible clinicians generally must include at least one applicable MIPS Core Measure in their quality reporting.

This replaces the previous requirement to report at least one outcome measure or, when an outcome measure was unavailable, another high-priority measure.

The requirement applies differently depending on the reporting pathway.

If a clinician does not have an applicable Core Measure available, the finalized policy provides an attestation process and requires reporting another applicable quality measure.

Small practices have a specific exception: they are not required to report a Core Measure or attest to the lack of an applicable Core Measure under this new requirement.

This does not mean small practices are automatically exempt from all MIPS quality reporting. They must still follow the other reporting requirements applicable to their participation status.

For billing and administrative teams, the practical priority is to identify the measures applicable to each clinician or group rather than assuming that the same quality reporting selections work for every specialty.

What Are the Three New MIPS Value Pathways for 2027?

MIPS Value Pathways organize quality reporting around clinical specialties and patient populations. Instead of selecting measures from a broad inventory without a defined clinical pathway, participating clinicians report through a more focused framework.

CMS finalized three additional MVPs for the 2027 performance period.

1. Diabetes MVP

The Diabetes MVP is designed for clinicians involved in managing diabetic disease. Its quality reporting framework supports performance measurement related to diabetes care and associated clinical outcomes.

Practices treating patients with diabetes should review the available measures, determine which apply to their patient population, and evaluate whether their clinical documentation captures the necessary information.

2. Hypertension MVP

The Hypertension MVP focuses on care delivered to patients with hypertension.

Clinicians should assess whether their existing workflows consistently capture relevant clinical information, including blood pressure measurements, treatment management, and applicable quality indicators.

3. Hospitalist MVP

The Hospitalist MVP provides a reporting pathway for clinicians delivering hospital-based care.

Hospital medicine groups should review the finalized pathway and determine how its measures relate to their existing documentation, patient management, and quality reporting processes.

These three additions expand the MVP inventory and provide more reporting options for clinicians in the relevant specialties.

However, a new pathway does not automatically mean every clinician in a related specialty must use it in 2027. Practices should verify eligibility, available pathways, and applicable reporting requirements before selecting a reporting method.

When Will Traditional MIPS End and MVP Reporting Become Mandatory?

The transition away from traditional MIPS is one of the most significant long-term changes in the 2027 Quality Payment Program Final Rule.

CMS initially proposed a faster transition, but the final rule gives clinicians additional time to prepare.

The finalized timeline is:

This timeline is important because the performance period and payment year are not the same.

For example, performance data collected during 2027 generally affects Medicare payment adjustments in 2029.

Practices should therefore plan ahead rather than waiting until the year a reporting change becomes mandatory.

The additional transition period gives clinicians time to review their specialty pathways, improve data collection, update administrative procedures, and establish reliable quality reporting processes.

Organizations participating in qualifying Advanced APM arrangements should separately review the applicable APM Performance Pathway requirements.

How Will the 2027 MIPS Changes Affect Medical Practices?

The new Core Measure requirement and expanded MVP inventory will affect more than the person responsible for submitting quality data.

Practices need coordination between clinical teams, administrative staff, EHR administrators, coding personnel, and quality reporting specialists.

Several operational areas deserve attention.

Quality measure selection: Practices should review the finalized measure inventory and identify applicable measures for each participating clinician or group.

Clinical documentation: Medical records must capture the information needed to support the selected quality measures. Missing or inconsistent documentation can affect reporting completeness and accuracy.

EHR configuration: Practices should confirm that their EHR systems can collect and extract the required clinical data for their selected measures.

Patient population review: Clinicians should understand which patients meet the relevant measure specifications and how patient encounters contribute to reporting requirements.

Reporting responsibility: Assign clear responsibilities for monitoring measure performance, reviewing data, and completing submissions.

Performance monitoring: Regularly evaluate reporting progress rather than waiting until the submission deadline to identify missing information.

These activities are especially important for independent practices and specialty groups with limited administrative resources. Without an organized process, clinicians may encounter incomplete data, reporting errors, or difficulty meeting applicable program requirements.

How Should Practices Prepare for the 2027 MIPS Reporting Requirements?

The best preparation approach is to review existing reporting processes before the 2027 performance period begins.

A structured implementation plan can help practices understand the new requirements and identify operational weaknesses.

1. Confirm MIPS participation status

Determine which clinicians are eligible for MIPS and whether they participate individually, as part of a group, through a virtual group, or through an applicable APM arrangement.

2. Review the finalized Core Measure inventory

Identify the Core Measures relevant to each clinician's specialty or subspecialty. Confirm whether an applicable measure is available and review the finalized exception process when it is not.

3. Evaluate MVP eligibility

Review the existing MVP inventory and the three new pathways for diabetes, hypertension, and hospitalists. Determine which reporting option best matches the practice's clinical activities.

4. Audit clinical documentation

Review patient records to identify missing information that could affect quality measure reporting. Pay particular attention to required clinical values, assessments, follow-up information, and documentation consistency.

5. Check EHR reporting capabilities

Work with your EHR vendor or technical team to confirm that required data can be captured, extracted, and validated.

6. Establish internal reporting schedules

Create recurring reviews to monitor data completeness, measure performance, and reporting responsibilities throughout the performance period.

7. Plan for the transition to MVPs

Even though traditional MIPS remains available through 2030, practices should begin evaluating their future reporting pathway early. This allows time to address specialty-specific gaps and improve reporting processes.

A professional medical billing and revenue cycle partner can support the administrative side of these preparations through documentation reviews, workflow assessments, and reporting process evaluations. Explore revenue cycle management services and practice analysis services to identify operational areas that may require improvement.

Why Professional Billing and Practice Management Support Matters for MIPS Compliance

MIPS reporting is a quality payment program responsibility, not simply a claim submission task. However, the underlying processes often depend on accurate patient information, consistent documentation, properly configured systems, and coordinated administrative workflows.

When these processes are disconnected, practices may struggle to produce complete quality data or identify performance issues early.

A structured review can help identify:

• Missing clinical documentation needed for quality measures.

• Inconsistent patient data across practice systems.

• Gaps between clinical workflows and reporting requirements.

• Unclear responsibilities for measure monitoring and submission.

• Administrative inefficiencies affecting reporting preparation.

• Opportunities to improve coordination between clinical and billing teams.

It is also important to distinguish MIPS quality reporting from ordinary medical claim billing. Reporting a quality measure does not automatically create a separately billable service or guarantee additional reimbursement. MIPS performance can affect Medicare payment adjustments under the applicable program rules.

The Medicator's supports healthcare practices with medical billing, coding, denial management, A/R management, and revenue cycle services. Practices can also consider a medical billing audit to review documentation and billing workflows that support accurate operational reporting.

Prepare Your Practice for the 2027 Medicare MIPS Changes

The 2027 MIPS updates introduce a new Core Measure requirement, expand specialty-focused reporting pathways, and establish a longer-term transition away from traditional MIPS.

Practices that review their reporting eligibility, documentation processes, EHR capabilities, and quality management workflows early can approach the transition with greater operational clarity.

Contact The Medicator's at (888) 277-1460 or request a consultation to discuss your medical billing and practice management needs.

Frequently Asked Questions

1. What are the major Medicare MIPS changes for 2027?

CMS finalized a new Core Measure reporting requirement, three additional MIPS Value Pathways for diabetes, hypertension, and hospitalists, and a longer transition timeline for ending traditional MIPS.

2. What is the new MIPS Core Measure requirement?

Beginning with the 2027 performance period, eligible clinicians generally must report at least one applicable MIPS Core Measure as part of their quality reporting, subject to finalized exceptions.

3. Which new MVPs are available in 2027?

CMS finalized three new pathways focused on diabetes, hypertension, and hospitalists. Clinicians should review the applicable pathway requirements before selecting a reporting method.

4. When will traditional MIPS end?

Traditional MIPS will remain available through the 2030 performance period. Beginning with the 2031 performance period, MVP reporting becomes the standard MIPS pathway for eligible clinicians who do not qualify to report through the APM Performance Pathway.

5. Are small practices exempt from the 2027 Core Measure requirement?

Yes. Under the finalized policy, small practices are not required to report a Core Measure or attest that no applicable Core Measure is available. This does not automatically exempt them from all other MIPS reporting requirements.

6. Does MIPS reporting directly affect medical billing reimbursement?

MIPS performance can affect Medicare payment adjustments in the applicable payment year. It is a quality payment program rather than a separate medical billing code or standalone reimbursement service.